Clearpoint Neuro Inc expected to post a loss of 20 cents a share - Earnings Preview
08/08/2025 23:54
Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected to show a rise in quarterly revenue when it reports results on August 12 for the period ending June 30 2025 The Solana Beach California-based company is expected to report a 17.1% increase in revenue to $9.2 million from $7.86 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data. LSEG's mean analyst estimate for Clearpoint Neuro Inc is for a loss of 20 cents per share. The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Clearpoint Neuro Inc is $29.00, about 62.7% above its last closing price of $10.82 This summary was machine generated August 8 at 22:54 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)